KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Inventory Average (2016 - 2025)

Jazz Pharmaceuticals has reported Inventory Average over the past 15 years, most recently at $450.0 million for Q4 2025.

  • Quarterly Inventory Average fell 11.74% to $450.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $450.0 million through Dec 2025, down 11.74% year-over-year, with the annual reading at $448.7 million for FY2025, 16.71% down from the prior year.
  • Inventory Average was $450.0 million for Q4 2025 at Jazz Pharmaceuticals, down from $494.0 million in the prior quarter.
  • Over five years, Inventory Average peaked at $1.2 billion in Q3 2021 and troughed at $105.4 million in Q1 2021.
  • The 5-year median for Inventory Average is $619.5 million (2023), against an average of $664.2 million.
  • Biggest five-year swings in Inventory Average: soared 1198.87% in 2021 and later plummeted 34.76% in 2022.
  • Tracing JAZZ's Inventory Average over 5 years: stood at $1.1 billion in 2021, then plummeted by 34.76% to $721.1 million in 2022, then fell by 16.18% to $604.4 million in 2023, then fell by 15.64% to $509.9 million in 2024, then fell by 11.74% to $450.0 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $450.0 million, $494.0 million, and $498.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.